首页> 美国卫生研究院文献>HPB : The Official Journal of the International Hepato Pancreato Biliary Association >Giant hemangiomas of the liver: surgical strategies and technical aspects
【2h】

Giant hemangiomas of the liver: surgical strategies and technical aspects

机译:肝脏巨大血管瘤:手术策略和技术方面

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The incidence of hemangiomas is 2–7% in the general population. We evaluated more than 300 patients with hepatic hemangiomas. Surgical removal of hepatic hemangiomas was performed in 48 cases due to uncertain diagnosis (2 cases), intractable symptoms (26 cases), size increase (18 cases), and liver failure in 2 cases that were treated by hepatic transplantation. In all, 26 patients underwent enucleation of hemangiomas or segmentectomies, while the remaining 20 patients underwent right lobectomies or left lateral segmentectomies. Blood transfusions were required in four cases (including two liver transplants); mean post-resection hospital stay was 6.3 days. We observed no perioperative mortality and only two cases of major morbidity (bile leaks not requiring reoperation). Our experience confirms that, after adequate patient selection, surgical treatment of hepatic hemangiomas is a very effective therapeutic choice with no mortality and low morbidity.
机译:在一般人群中,血管瘤的发生率为2–7%。我们评估了300多例肝血管瘤患者。由于肝移植的诊断不明确(2例),顽固性症状(26例),体型增大(18例)和肝功能衰竭,有2例手术切除了肝血管瘤48例。总共有26例接受了血管瘤或节段切除术摘除术,而其余20例则进行了右肺叶切除术或左外侧节段切除术。四例(包括两例肝移植)需要输血;切除后平均住院天数为6.3天。我们没有观察到围手术期的死亡率,只有两例严重的发病率(胆汁渗漏不需要再次手术)。我们的经验证实,在对患者进行充分的选择之后,手术治疗肝血管瘤是一种非常有效的治疗选择,且无死亡率和低发病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号